Insulins: past, present, and future.
نویسندگان
چکیده
This article highlights selected milestones in insulin discovery and its continued development as a pivotal therapy for diabetes. The last 90 years have witnessed tremendous progress in insulin therapy, from the initial crude, yet life-saving, animal insulin extracts to novel human insulin analogues. Although the complete physiologic replacement of insulin is inherently difficult to achieve with open-loop subcutaneously administered insulin, the continued development of improved injectable insulin formulations with superior pharmacokinetics and pharmacodynamics will enhance glucose control, and represents important clinical advances in the treatment of both type 1 and type 2 diabetes.
منابع مشابه
Climate Change Modeling and Drought Detection of Lake Neor by Approaching to Past, Present, and Future
این مقاله فاقد چکیده میباشد.
متن کاملMizaj past, present and future
Temperament (Mizaj), as an individual factor, has great importance in traditional medicine and its use in diagnosis and treatment of diseases, as well as the individual lifestyle is very common. Since medicine moves toward Personalized Medicine, the root of individual differences will find its position in different aspects of medicine in early future. In traditional medicine, temperament is ...
متن کاملTeachers’ Professional Competencies: Past, Present, and Future
Teachers’ Professional Competencies: Past, Present, and Future M. Rezaai, Ph.D.* The purpose of this paper is to review the expected professional competencies throughout the history of teacher training in Iran. As such it covers both the past, covering the period from teacher training inception in 1918 to the Islamic revolution in 1979; and the present, since the revolution. Of course t...
متن کاملEnteric redmouth disease: Past, present and future: A review
Enteric red mouth disease (also known as Yersiniosis) is one of the most significant bacterial infections in coldwater fish farms that cause significant mortalities and economical losses in the salmonids fish farms, especially in rainbow trout (Oncorhynchus mykiss). ERM is caused by the gram negative pathogen bacteria Yersinia ruckeri that has five O-serotypes (O1, O2, O5, O6 and O7), five oute...
متن کاملBiosimilar insulins: a European perspective
Biosimilar insulins are likely to enter clinical practice in Europe in the near future. It is important that clinicians are familiar with and understand the concept of biosimilarity and how a biosimilar drug may differ from its reference product. The present article provides an overview of biosimilars, the European regulatory requirements for biosimilars and safety issues. It also summarizes th...
متن کاملCurrent and Future Perspectives on the Development of Biosimilar Insulins for Diabetes Management
• The European Medical Agency (EMA) has issued regulatory guidelines for the development of biosimilar insulins that emphasize pharmacokinetic/pharmacodynamic studies rather than efficacy evaluations. In the United States, biosimilar insulins are currently covered by the Food and Drug Administration’s (FDA) 505(b)(2) pathway permitting evaluation of the reference product. Current and Future Per...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Endocrinology and metabolism clinics of North America
دوره 41 1 شماره
صفحات -
تاریخ انتشار 2012